Penumbra PE Ratio 2014-2019 | PEN
Current and historical p/e ratio for Penumbra (PEN) from 2014 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Penumbra PE ratio as of November 21, 2019 is 191.78.
| Penumbra PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2019-11-21 | 167.43 | 132.88 | |
| 2019-09-30 | 134.49 | $1.26 | 106.74 |
| 2019-06-30 | 160.00 | $0.39 | 410.26 |
| 2019-03-31 | 147.01 | $0.30 | 490.03 |
| 2018-12-31 | 122.20 | $0.15 | 814.67 |
| 2018-09-30 | 149.70 | $0.22 | 680.45 |
| 2018-06-30 | 138.15 | $0.78 | 177.12 |
| 2018-03-31 | 115.65 | $0.36 | 321.25 |
| 2017-12-31 | 94.10 | $0.11 | 855.45 |
| 2017-09-30 | 90.30 | $-0.22 | 0.00 |
| 2017-06-30 | 87.75 | $-0.27 | 0.00 |
| 2017-03-31 | 83.45 | $-0.21 | 0.00 |
| 2016-12-31 | 63.80 | $-0.09 | 0.00 |
| 2016-09-30 | 75.99 | $0.04 | 1899.75 |
| 2016-06-30 | 59.50 | $0.11 | 540.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.892B | $0.445B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $122.872B | 25.45 |
| Intuitive Surgical (ISRG) | United States | $66.778B | 52.48 |
| Edwards Lifesciences (EW) | United States | $50.799B | 46.13 |
| IDEXX Laboratories (IDXX) | United States | $22.698B | 54.90 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $22.488B | 15.22 |
| Olympus (OCPNY) | Japan | $21.073B | 158.26 |
| DexCom (DXCM) | United States | $19.915B | 178.34 |
| Teleflex (TFX) | United States | $16.381B | 33.26 |
| Sysmex ADR (SSMXY) | Japan | $14.885B | 40.07 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.154B | 0.00 |
| STERIS (STE) | Ireland | $12.878B | 28.44 |
| Hologic (HOLX) | United States | $12.603B | 19.32 |
| Varian Medical Systems (VAR) | United States | $11.699B | 27.69 |
| ABIOMED (ABMD) | United States | $8.324B | 45.29 |
| Masimo (MASI) | United States | $8.172B | 48.80 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Globus Medical (GMED) | United States | $5.547B | 34.23 |
| Integra LifeSciences Holdings (IART) | United States | $5.059B | 21.74 |
| Elekta AB (EKTAY) | Sweden | $4.779B | 36.79 |
| Tandem Diabetes Care (TNDM) | United States | $3.944B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.834B | 27.60 |
| Wright Medical Group (WMGI) | Netherlands | $3.755B | 227.62 |
| Nevro (NVRO) | United States | $3.248B | 0.00 |
| Cantel Medical (CMD) | United States | $3.080B | 30.53 |
| Integer Holdings (ITGR) | United States | $2.420B | 16.57 |
| Nihon Kohden (NHNKY) | Japan | $2.365B | 23.79 |
| Glaukos (GKOS) | United States | $2.281B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.584B | 31.18 |
| Inogen (INGN) | United States | $1.566B | 49.43 |
| Veracyte (VCYT) | United States | $1.268B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.119B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.104B | 126.15 |
| Natus Medical (NTUS) | United States | $1.096B | 26.35 |
| OPKO Health (OPK) | United States | $1.018B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $1.011B | 37.48 |
| CryoLife (CRY) | United States | $0.923B | 94.61 |
| Accelerate Diagnostics (AXDX) | United States | $0.908B | 0.00 |
| Luminex (LMNX) | United States | $0.892B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.854B | 28.37 |
| Pacific Biosciences Of California (PACB) | United States | $0.717B | 0.00 |
| Intersect ENT (XENT) | United States | $0.673B | 0.00 |
| AxoGen (AXGN) | United States | $0.615B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.582B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.572B | 20.55 |
| Quotient (QTNT) | Switzerland | $0.553B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.447B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.441B | 13.33 |
| Si-Bone (SIBN) | United States | $0.437B | 0.00 |
| Sientra (SIEN) | United States | $0.394B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.326B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.290B | 39.09 |
| ViewRay (VRAY) | United States | $0.288B | 0.00 |
| IRadimed (IRMD) | United States | $0.269B | 37.74 |
| Stereotaxis (STXS) | United States | $0.250B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.247B | 0.00 |
| Accuray (ARAY) | United States | $0.245B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.208B | 58.00 |
| Fluidigm (FLDM) | United States | $0.161B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.145B | 39.20 |
| EDAP TMS S.A (EDAP) | France | $0.141B | 37.38 |
| ConforMIS (CFMS) | United States | $0.124B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.104B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.097B | 0.00 |
| Electromed (ELMD) | United States | $0.084B | 30.21 |
| T2 Biosystems (TTOO) | United States | $0.084B | 0.00 |
| Neuronetics (STIM) | United States | $0.077B | 0.00 |
| Vermillion (VRML) | United States | $0.071B | 0.00 |
| TransEnterix (TRXC) | United States | $0.064B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.061B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.059B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.042B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.040B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.040B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.024B | 0.00 |
| Neovasc (NVCN) | Canada | $0.021B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.019B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.019B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.015B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 20.13 |
| OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
| Avinger (AVGR) | United States | $0.013B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.013B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.009B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.009B | 0.00 |
| Restoration Robotics (VERO) | Canada | $0.009B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Dynatronics (DYNT) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
| Nuvectra (NVTR) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| InspireMD (NSPR) | Israel | $0.001B | 0.00 |
